换一批
换一批Molecular characterization and clinical outcome of B-cell precursor acute lymphoblastic leukemia with IG-MYC rearrangement.
作者：
Simon,Bomken [1]
;
Amir,Enshaei [2]
;
Edward C,Schwalbe [3]
;
Aneta,Mikulasova [4]
;
Yunfeng,Dai [5]
;
Masood,Zaka [6]
;
Kent T M,Fung [2]
;
Matthew,Bashton [7]
;
Huezin,Lim [2]
;
Lisa,Jones [2]
;
Nefeli,Karataraki [2]
;
Emily,Winterman [2]
;
Cody,Ashby [8]
;
Andishe,Attarbaschi [9]
;
Yves,Bertrand [10]
;
Jutta,Bradtke [11]
;
Barbara,Buldini [12]
;
G A Amos,Burke [13]
;
Giovanni,Cazzaniga [14]
;
Gudrun,Gohring [15]
;
Hesta A,De Groot-Kruseman [16]
;
Claudia,Haferlach [17]
;
Luca Lo,Nigro [18]
;
Mayur,Parihar [19]
;
Adriana,Plesa [20]
;
Emma,Seaford [21]
;
Edwin,Sonneveld [22]
;
Sabine,Strehl [23]
;
Vincent H J,Van der Velden [24]
;
Vikki,Rand [6]
;
Stephen P,Hunger [25]
;
Christine J,Harrison [2]
;
Chris M,Bacon [26]
;
Frederik W,Van Delft [26]
;
Mignon L,Loh [27]
;
John,Moppett [21]
;
Josef,Vormoor [28]
;
Brian A,Walker [29]
;
Anthony V,Moorman [2]
;
Lisa J,Russell [30]
作者单位：
Wolfson Childhood Cancer Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom; The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne. s.n.bomken@newcastle.ac.uk.
[1]
Wolfson Childhood Cancer Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne.
[2]
Department of Applied Sciences, Northumbria University, Newcastle upon Tyne.
[3]
Biosciences Institute, Newcastle University, Newcastle upon Tyne.
[4]
Department of Biostatistics, Colleges of Medicine, Public Health and Health Professions, University of Florida, Gainesville, Florida.
[5]
School of Health and Life Sciences, Teesside University, Middlesbrough, UK; National Horizons Centre, Teesside University, Darlington.
[6]
The Hub for Biotechnology in the Built Environment, Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne.
[7]
Department of Biomedical Informatics / Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas.
[8]
St Anna Children's Hospital, Medical University of Vienna, Vienna.
[9]
Department of Institute of Hematology Oncology Pediatric (IHOP), Hospices Civils de Lyon, Lyon.
[10]
Institute of Pathology, Department Cytogenetics, University Hospital Giessen and Marburg.
[11]
Maternal and Child Health Department, Padua University.
[12]
Department of Paediatric Haematology, Oncology, and Palliative Care, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge.
[13]
School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy; Centro Ricerca Tettamanti, University of Milano-Bicocca, Monza.
[14]
Department of Human Genetics, Hannover Medical School, Hannover.
[15]
Dutch Childhood Oncology Group (DCOG), Utrecht, The Netherlands; Princess Maxima Center for Pediatric Oncology, Utrecht.
[16]
MLL Munich Leukemia Laboratory, Munich.
[17]
Head of Cytogenetic-Cytofluorimetric-Molecular Biology Laboratory, Center of Pediatric Hematology Oncology, Azienda Policlinico "G. Rodolico - San Marco", Catania.
[18]
Department of Cytogenetics and Laboratory Haematology, Tata Medical Centre, Kolkata, India.
[19]
Hematology and Flow cytometry Laboratory, Lyon Sud University Hospital, Hospices Civils de Lyon, Lyon.
[20]
Department of Paediatric Oncology, Bristol Royal Hospital for Children, Bristol.
[21]
Princess Maxima Center for Pediatric Oncology, Utrecht.
[22]
St. Anna Children's Cancer Research Institute, Vienna.
[23]
Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam.
[24]
Department of Pediatrics and the Center for Childhood Cancer Research, Children's Hospital of Philadelphia and the Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
[25]
Wolfson Childhood Cancer Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom; The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne.
[26]
Department of Pediatrics, Benioff Children's Hospital and the Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA.
[27]
Wolfson Childhood Cancer Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom; Princess Maxima Center for Pediatric Oncology, Utrecht.
[28]
Melvin and Bren Simon Comprehensive Cancer Center, Division of Hematology Oncology, Indiana University, Indianapolis, IN.
[29]
Wolfson Childhood Cancer Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne. lisa.russell@newcastle.ac.uk.
[30]
主题词
儿童(Child);人类(Humans);伯基特淋巴瘤(Burkitt Lymphoma);前瞻性研究(Prospective Studies);免疫球蛋白类(Immunoglobulins);基因重排(Gene Rearrangement);前体B细胞淋巴母细胞白血病淋巴瘤(Precursor B-Cell Lymphoblastic Leukemia-Lymphoma)
DOI
10.3324/haematol.2021.280557
PMID
35484682
发布时间
2023-09-13
- 浏览7
Haematologica
Haematologica
717-731页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
